Mehta Vibha, Ramachandran Krithiga, Agarwal Reshu, Alam Seema, Pamecha Viniyendra, Gupta Ekta
Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.
Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
J Glob Infect Dis. 2021 Aug 19;13(3):142-144. doi: 10.4103/jgid.jgid_233_20. eCollection 2021 Jul-Sep.
Varicella-zoster virus (VZV) is a DNA virus belonging to the Herpesviridae family. Primary infection causes chickenpox followed by latency in the sensory ganglia, which can sometimes reactivate leading to herpes zoster. Chicken pox is generally a mild disease of childhood with a secondary attack rate of >85%, but disseminated VZV infection with visceral involvement and fatal outcome may occur in immunocompromised individuals. Indian Academy of Pediatrics recommends two doses of live-attenuated varicella vaccine in healthy unexposed children at 15-18 months and then at 4-6 years of age. The effectiveness of a single dose of vaccine is around 85% and with a two-dose schedule is as high as 92%. Despite the vaccine-induced protection, community-acquired VZV infections still remain a problem in immunocompromised population. We hereby report a case of a previously immunized pediatric liver-transplant recipient who acquired VZV infection. This case report clearly highlights the importance of strict environmental infection control practices, early suspicion, diagnosis, and management in such cases.
水痘带状疱疹病毒(VZV)是一种属于疱疹病毒科的DNA病毒。初次感染会引发水痘,随后病毒潜伏在感觉神经节中,有时会重新激活导致带状疱疹。水痘通常是一种儿童期的轻症疾病,二次感染率>85%,但免疫功能低下的个体可能会发生播散性VZV感染并累及内脏,甚至导致死亡。印度儿科学会建议,健康且未接触过水痘的儿童在15至18个月龄时接种两剂减毒活水痘疫苗,然后在4至6岁时再接种一剂。单剂疫苗的有效性约为85%,两剂接种方案的有效性高达92%。尽管疫苗提供了保护,但社区获得性VZV感染在免疫功能低下人群中仍然是一个问题。我们在此报告一例先前已接种疫苗的小儿肝移植受者感染VZV的病例。本病例报告清楚地强调了在此类病例中严格的环境感染控制措施、早期怀疑、诊断和管理的重要性。